Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis
about
Validation study of genes with hypermethylated promoter regions associated with prostate cancer recurrence.EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.Higher FOXP3-TSDR demethylation rates in adjacent normal tissues in patients with colon cancer were associated with worse survival.Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas.CpG island methylation profiling in human salivary gland adenoid cystic carcinoma.Epigenetics in prostate cancer.DNA methylation changes in prostate cancer: current developments and future clinical implementation.Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo.Identification of endometrial cancer methylation features using combined methylation analysis methods.Mammalian alpha beta hydrolase domain (ABHD) proteins: Lipid metabolizing enzymes at the interface of cell signaling and energy metabolism.CD44 Reciprocally regulates the differentiation of encephalitogenic Th1/Th17 and Th2/regulatory T cells through epigenetic modulation involving DNA methylation of cytokine gene promoters, thereby controlling the development of experimental autoimmunIdentification of a small optimal subset of CpG sites as bio-markers from high-throughput DNA methylation profilesBetter cancer biomarker discovery through better study design.Methylation markers for prostate cancer prognosis: a systematic review.Novel approaches for the identification of biomarkers of aggressive prostate cancerProstate cancer epigenetic biomarkers: next-generation technologies.Prognostic DNA methylation markers for prostate cancer.Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative Colitis.Large-scale evaluation of SLC18A2 in prostate cancer reveals diagnostic and prognostic biomarker potential at three molecular levelsComprehensive DNA methylation analysis of benign and malignant adrenocortical tumors.A cancer specific hypermethylation signature of the TERT promoter predicts biochemical relapse in prostate cancer: a retrospective cohort study.High expression of the evolutionarily conserved alpha/beta hydrolase domain containing 6 (ABHD6) in Ewing tumors.The Plasticity and Stability of Regulatory T Cells during Viral-Induced Inflammatory Lesions.Development of a diagnostic microarray assay to assess the risk of recurrence of prostate cancer based on PITX2 DNA methylation.DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence.Aberrant methylation of PCDH10 predicts worse biochemical recurrence-free survival in patients with prostate cancer after radical prostatectomy.Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer.Good Manufacturing Practice-Compliant Production and Lot-Release of Ex Vivo Expanded Regulatory T Cells As Basis for Treatment of Patients with Autoimmune and Inflammatory Disorders.Sequence analysis and structure prediction of ABHD16A and the roles of the ABHD family members in human disease.Cancer and epigenetics
P2860
Q30582750-14D73E82-75FC-40A7-BFC3-ECB04DDCB05CQ33288850-57913147-6350-4BBB-B73C-298C577E1F2EQ33818673-E056A3B4-BA93-45A7-967D-55A3EF383DB0Q34170505-27669132-E0FC-499B-87B5-8E5AFB3094CCQ35069629-DF9F2A7F-6A23-4BC2-B600-697B10BA9550Q35608952-2D1E6233-291A-4CA3-B733-70303FD1A755Q35636543-73CCA703-4A8E-4D59-B695-9CC004A10893Q36278029-D14D942D-73D7-40CE-B925-502447E189BFQ36302529-FD5DE7E5-E9DA-44FF-BCB7-D08B472DBB36Q36612260-01AEDD9D-749A-4004-88FE-A41EA525C31DQ36831813-7CDE61B4-3071-4AF3-B3FB-8E79EBC13553Q37037183-5D33EEC5-6231-4DA5-B1DC-CC7B218785A6Q37310041-4C479F20-AE8D-47FD-8138-C68C58123E3CQ38116745-C7B0990B-688C-47D3-8A74-32BFB01E68C6Q38117841-F534561A-0736-43F9-A32B-727655E08BB4Q38212471-5C88826B-4F51-4FA9-9A04-1C52F03DC3D0Q38252624-6F8F24CB-AE5B-4B08-AEAD-78CCADF746BBQ38657587-0284B5FB-B018-4DD4-87EF-F7100D6B9D50Q38904571-8D0258AC-5A30-4248-977C-324D177EBEF6Q39325094-1249AD3B-9929-441A-A39C-BDA1D8701153Q39581362-19D6AFAC-4685-4CEE-9F64-4F66721F57FDQ39793314-D02D9ED4-AED2-4005-BA60-1C55579F90CAQ40122066-FC7F7A64-3C05-4CEE-9E31-45D237B6E594Q40222443-18313F23-2341-4168-AF84-5185F421655CQ40581966-EDF1DAC2-1BB7-4513-85B1-3AB8F609C397Q42804809-39DFBD40-BD43-4F81-811B-4900B053FCD5Q42950544-8954D7A9-E795-4FAF-9D9E-563AE4A01677Q47138817-3BA70048-46D6-4343-BA65-3740A73F824BQ55441249-9BE0B42B-B058-4819-871B-D2366D8E72E2Q58132355-F3921BAA-ABBB-49F2-B195-E2EDAED49C9F
P2860
Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis
@ast
Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis
@en
Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis
@nl
type
label
Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis
@ast
Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis
@en
Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis
@nl
prefLabel
Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis
@ast
Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis
@en
Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis
@nl
P2093
P3181
P1476
Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis
@en
P2093
Arndt Hartmann
Axel Semjonow
Carolina Haefliger
Elke Eltze
Glen Kristiansen
Gunter Weiss
Michael Ittmann
Susan Cottrell
Thomas Stamey
P304
P3181
P356
10.1016/J.JURO.2007.01.010
P407
P50
P577
2007-05-01T00:00:00Z